Related Experiment Video

Updated: May 19, 2026

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
11:38

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation

Published on: October 4, 2024

Induced pluripotent cells in cardiovascular biology: epigenetics, promises, and challenges

Eneda Hoxha1, Raj Kishore

  • 1Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Progress in Molecular Biology and Translational Science
|August 25, 2012
PubMed

Insights

Induced pluripotent stem (iPS) cells offer promising potential for repairing heart tissue damaged by myocardial infarction (MI). Research explores their generation, differentiation, and epigenetic memory for effective cardiac cell transplantation therapies.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Cardiovascular diseases remain the leading global cause of mortality.
  • Acute myocardial infarction (MI) results in significant cardiomyocyte and microvasculature loss, contributing to ongoing mortality risk.
  • Therapeutic strategies focus on preserving or regenerating myocardial tissue post-MI.

Purpose of the Study:

  • To review the potential of induced pluripotent stem (iPS) cells for myocardial repair.
  • To examine the generation, differentiation capabilities, and epigenetic mechanisms of iPS cells.
  • To assess the therapeutic potential and limitations of iPS cells in cardiovascular applications.

Main Methods:

  • Review of existing literature on iPS cell generation and cardiovascular differentiation.
  • Analysis of epigenetic mechanisms involved in iPS cell reprogramming and pluripotency maintenance.
  • Evaluation of studies on the therapeutic efficacy and potential of iPS cell transplantation.

Main Results:

  • iPS cells show significant potential for generating cardiomyocytes for transplantation.
  • Epigenetic mechanisms play a crucial role in iPS cell reprogramming, pluripotency, and differentiation.
  • Understanding epigenetic memory is key to optimizing iPS cell therapeutic applications.

Conclusions:

  • iPS cells represent a promising source for myocardial regeneration after MI.
  • Further understanding of iPS cell molecular circuitry and epigenetic factors is essential for clinical translation.
  • Optimizing iPS cell differentiation and transplantation holds potential for improving cardiovascular disease outcomes.

More Related Videos

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.